LENZ

NASDAQStock

LENZ Therapeutics, Inc.

$11.97+0.15 (+1.27%)

52-Week Range

$11.59
$49.05

Key Stats

Market Cap

374.5M

P/E Ratio

Dividend Yield

58.49%

Beta

0.51

Volume

496.9K

Avg Volume

681.7K

Performance

1M

-8.87%

3M

-30.80%

6M

-70.46%

YTD

-26.13%

1Y

-53.56%

3Y

-27.04%

5Y

-27.04%

Price Chart

ETF Exposure

LENZ is held by 72 ETFs

ETFFund NameWeight
DFAUDimensional - US Core Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
PreviousPage 2 of 2

About LENZ ETF Exposure

LENZ Therapeutics, Inc. (LENZ) is held by 72 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 374.5M, LENZ is a widely held institutional stock. The stock currently trades at $11.97 with a dividend yield of 58.49%. Investors can gain exposure to LENZ through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LENZ, sorted by portfolio weight.